alogliptin NDA

Related by string. * Alogliptin : alogliptin ACTOS . alogliptin / NDAS . nda . Nda . NDAs : NDA convenor Sharad Yadav . NDA convener George . NDA convener . NDA submission . NDA Convener George . NDA convenor George . Alliance NDA . erstwhile NDA . Intermezzo ® NDA . NDA Convenor George . Alliance NDA convenor . lorcaserin NDA . NDA convenor . Investigational NDAs . NDA Convenor . NDA resubmission * *

Related by context. Frequent words. (Click for all words.) 59 FDA approvable letter 59 Complete Response letter 56 BLA submission 54 Complete Response Letter 54 NYSE Euronext PHARM 53 Application BLA 53 supplemental Biologics License Application 53 Complete Response 53 alogliptin 52 Act PDUFA date 52 PDUFA date 51 Biologics License Application 51 SILENOR TM 51 TOCOSOL Paclitaxel 50 NASDAQ DYAX 50 Omigard 50 Gestiva 50 Biologics License Application BLA 50 stockholder approvals 50 Approvable Letter 50 timelines communicated 50 Exalgo 50 Phenoptin 49 PMA submission 49 Inc. Nasdaq SEPR 49 approvable letter 49 Marketing Authorization Application 49 contacting 7thSpace Interactive 49 website www.standardandpoors.com 49 Exelbine 49 Nasdaq VRTX 49 sNDA 49 Inc. Nasdaq ARNA 49 ezogabine 48 VeriSign undertakes 48 sBLA 48 NEBIDO 48 CHMP opinion 48 application sNDA 48 By Justin Berka 48 Nasdaq ITMN 48 Rhucin ® 48 BioDelivery Sciences 48 Corporation Nasdaq GENZ 48 FavId 47 refractory chronic lymphocytic 47 Palatin Technologies Inc. 47 liprotamase 47 Zelrix 47 rhThrombin 47 NDA submission 47 Ixempra 47 alvimopan 47 Calpine undertakes 47 Replagal 47 MONOVISC 47 bazedoxifene 47 talactoferrin 47 Junovan 47 PreciseTrader.com 47 Act PDUFA 47 Nasdaq BDSI 47 By Eric Bangeman 46 PROPEL trial 46 Inc. Nasdaq MYL 46 Inc. Nasdaq NVAX 46 resubmission 46 Reader Comment Guidelines 46 NASDAQ ARIA 46 * Potentially libelous 46 Market Approval PMA 46 Arigene 46 modestly dilutive 46 Fusilev 46 Sandstorm Resources 46 Inc. Nasdaq DSCO 46 Dainippon Sumitomo 46 By Joel Hruska 46 EFAPROXYN 46 Lumizyme 46 MOZOBIL 46 Renvela 46 through GroupWeb EmailWire.Com 46 BYDUREON 46 Marketing Authorization Application MAA 46 pediatric exclusivity 46 approvability 46 updated NI #-# 46 European Medicines Evaluation 46 cervical cancer vaccine Cervarix 46 Interim Filings 46 BENLYSTA 46 InKine 46 Sensipar 46 Solzira 46 JZP 6 45 Krystexxa 45 regulatory approval 45 FIRAZYR 45 Rotarix R 45 Onsolis

Back to home page